Category
Health
5 news items
Everest Medicines Launches VELSIPITY(R) in China for Ulcerative Colitis
Everest Medicines has announced the commercial launch of VELSIPITY(R) in Mainland China, with the first prescription issued at Sun Yat-sen University First Affiliated Hospital. The drug is now accessible in eight major cities nationwide.
2 June 2026
AAX Biotech to Showcase Novel Antibody Technology at PEGS Boston
AAX Biotech's Head of R&D will present the company's Opti-mAb® technology at the PEGS Boston 2026 conference. The innovation aims to overcome the instability challenges of scFv antibodies.
2 June 2026
AAX Biotech and evitria Partner to Expand Access to Opti-mAb® Technology
AAX Biotech announced a partnership with evitria AG to allow broader access to its Opti-mAb® technology in early antibody development. This collaboration aims to enhance the design and optimization of antibody candidates.
2 June 2026
AAX Biotech to Showcase Pioneering Antibody Therapies at BIO-Europe Spring 2026
AAX Biotech will attend the BIO-Europe Spring conference in Lisbon in March 2026. The company will showcase its advanced Seqitope® and Opti-mAb® platforms, redefining antibody therapy development.
2 June 2026
AAX Biotech Presents Opti-mAb® at Antibody Engineering & Therapeutics Europe
AAX Biotech is set to attend the Antibody Engineering & Therapeutics Europe conference in Basel, where it will showcase its groundbreaking Opti-mAb® technology. This innovation promises to significantly enhance the production yields and stability of scFv antibodies.
2 June 2026